scholarly article | Q13442814 |
P50 | author | Ralph H. Hruban | Q21063634 |
P2093 | author name string | Gloria H Su | |
Wanglong Qiu | |||
Dario Garcia-Carracedo | |||
Zong-Ming Chen | |||
Sophia M Tang | |||
Alicia S Huang | |||
P2860 | cites work | Mutations of PIK3CA in gastric adenocarcinoma | Q21261219 |
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus | Q24600932 | ||
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 | ||
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer | Q27646556 | ||
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic | Q27824826 | ||
High frequency of mutations of the PIK3CA gene in human cancers | Q28131776 | ||
The biology and clinical relevance of the PTEN tumor suppressor pathway | Q28272157 | ||
The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
Absence of AKT1 mutations in glioblastoma | Q30439629 | ||
Mucinous cystic neoplasms of the pancreas | Q33865956 | ||
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers | Q33987852 | ||
Cancer-specific mutations in PIK3CA are oncogenic in vivo | Q34335169 | ||
Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment | Q34620062 | ||
PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas | Q35606891 | ||
Clinical importance of precursor lesions in the pancreas | Q36829541 | ||
Cystic neoplasia of the pancreas: pathology and biology | Q36980389 | ||
Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance | Q37036297 | ||
Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer | Q37474182 | ||
PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. | Q37558625 | ||
Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma | Q38445188 | ||
PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma | Q40218014 | ||
PIK3CA mutations in head and neck squamous cell carcinoma | Q40305620 | ||
Mutation of the PIK3CA gene in anaplastic thyroid cancer. | Q40351486 | ||
Mutant PIK3CA promotes cell growth and invasion of human cancer cells | Q40410776 | ||
Functional consequences of mutations in a putative Akt phosphorylation motif of B-raf in human cancers | Q40442452 | ||
Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion. | Q40462546 | ||
PIK3CA mutations in advanced ovarian carcinomas | Q43723490 | ||
PIK3CA is implicated as an oncogene in ovarian cancer. | Q46015944 | ||
PIK3CA mutations in nasopharyngeal carcinoma. | Q53355100 | ||
Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases. | Q53417898 | ||
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. | Q53629192 | ||
Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas. | Q54672534 | ||
Tumor-suppressing pathways in cystic pancreatic tumors. | Q54798453 | ||
Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas | Q57293479 | ||
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. | Q64937598 | ||
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas | Q72016451 | ||
p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy | Q73045964 | ||
Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy | Q73086227 | ||
Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression | Q73183545 | ||
Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? | Q73448078 | ||
Oncogenic mutations of PIK3CA in human cancers | Q80826963 | ||
Mutation of the PIK3CA gene in ovarian and breast cancer | Q80945762 | ||
P433 | issue | 2 | |
P921 | main subject | pancreas | Q9618 |
P304 | page(s) | 245-249 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | Pancreas | Q15762014 |
P1476 | title | PIK3CA mutations in mucinous cystic neoplasms of the pancreas | |
P478 | volume | 43 |
Q28082890 | A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas |
Q93001657 | Advanced diagnostics for pancreatic cysts: Confocal endomicroscopy and molecular analysis |
Q49629569 | Confocal endomicroscopy and cyst fluid molecular analysis: Comprehensive evaluation of pancreatic cysts |
Q39238536 | DNA testing of pancreatic cyst fluid: is it ready for prime time? |
Q90135274 | Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines |
Q30234478 | Insights into the Pathogenesis of Pancreatic Cystic Neoplasms |
Q89918641 | Molecular markers contribute to the clinical diagnosis for pancreatic cystic neoplasms |
Q48344381 | Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression. |
Q48310994 | Mucinous cystic neoplasms of the pancreas: high-resolution cross-sectional imaging features with clinico-pathologic correlation. |
Q38757526 | Novel Biomarkers for Pancreatic Cysts |
Q26799446 | Pancreatic adenocarcinoma pathology: changing "landscape" |
Q89125881 | Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia |
Q53622486 | [Classification and malignant potential of pancreatic cystic tumors]. |
Search more.